Skip to main content

Laparotomy

1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
1
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Pharmbio Korea
Pharmbio KoreaKorea - Seoul
1 program
1
NefopamPhase 2/31 trial
Active Trials
NCT02596269Completed73Est. Sep 2013
Cogent Biosciences
1 program
REBUILD BioabsorbableN/A1 trial
Active Trials
NCT05041530Unknown30Est. Jun 2023
Heidelberg Pharma
Heidelberg PharmaGermany - Ladenburg
1 program
Interrupted suturesPHASE_2_31 trial
Active Trials
NCT00544583Unknown80Est. Apr 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Pharmbio KoreaNefopam
Heidelberg PharmaInterrupted sutures
Cogent BiosciencesREBUILD Bioabsorbable

Clinical Trials (3)

Total enrollment: 183 patients across 3 trials

Nefopam/Fentanyl Postoperative Intravenous Patient-Controlled-Analgesia

Start: Oct 2012Est. completion: Sep 201373 patients
Phase 2/3Completed
NCT00544583Heidelberg PharmaInterrupted sutures

Continuous Versus Interrupted Abdominal Wall Closure After Emergency Midline Laparotomy

Start: Nov 2007Est. completion: Apr 201280 patients
Phase 2/3Unknown
NCT05041530Cogent BiosciencesREBUILD Bioabsorbable

Abdominal Wall Closure After Laparotomy in Oncologic Surgery

Start: Jun 2022Est. completion: Jun 202330 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.